1. Circulating Epstein–Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma. (July 2021) Authors: Chen, Fo-Ping; Luo, Ying-Shan; Chen, Kai; Li, Jun-Yun; Huo, Lan-Qing; Shi, Liu; Ou-Yang, Yi; Cao, Xin-Ping Journal: European journal of cancer Issue: Volume 151(2021) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10, 149 endemic cases. (October 2021) Authors: Chen, Fo-Ping; Lin, Li; Liang, Jin-Hui; Tan, Sze Huey; Ong, Enya H.W.; Luo, Ying-Shan; Huang, Luo; Sim, Adelene Y.L.; Wang, Hai-Tao; Gao, Tian-Sheng; Deng, Bin; Zhou, Guan-Qun; Kou, Jia; Chua, Melvin L.K.; Sun, Ying Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti–programmed death-1 and anti–programmed death ligand 1 trials. (January 2019) Authors: Nie, Run-Cong; Chen, Fo-Ping; Yuan, Shu-Qiang; Luo, Ying-Shan; Chen, Shi; Chen, Yong-Ming; Chen, Xiao-Jiang; Chen, Ying-Bo; Li, Yuan-Fang; Zhou, Zhi-Wei Journal: European journal of cancer Issue: Volume 106(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis. (6th May 2020) Authors: Nie, Run-Cong; Zhao, Chong-Bang; Xia, Xiao-Wei; Luo, Ying-Shan; Wu, Ting; Zhou, Zhi-Wei; Yuan, Shu-Qiang; Wang, Yun; Li, Yuan-Fang Other Names: Upham Brad Academic Editor. Journal: BioMed research international Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗